In vivo, USP14 inhibition corrected mitochondrial dysfunction and locomotion impairment in the established PINK1 and Parkin mutant Drosophila model of neurodegeneration, highlighting the potential of USP14 inhibitors as therapeutics for PD symptoms. Here, USP14 is linked to Parkinson disease.